IMRN

Immuron Ltd IMRN

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $7.7M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$7.71M

Quarter to Jun 30

Net income

$-3.68M

Quarter to Jun 30

Free cash flow

$-3.26M

Quarter to Jun 30

Operating margin

-49.9%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$61.2K total
CITADEL ADVISORS LLC
$45.7K+212.4%
RHUMBLINE ADVISERS
$7.8K0.0%
BNP PARIBAS FINANCIAL MARKETS
$5.5K+13.0%
MORGAN STANLEY
$1.8K-94.4%
UBS Group AG
$385New
HRT FINANCIAL LP
$21New
See all 6 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2026
EDGAR

Net Income

FY 2026
EDGAR

EPS (Diluted)

FY 2026
EDGAR

Operating Margin

FY 2026
EDGAR

ROIC

FY 2026
EDGAR

Free Cash Flow

FY 2026
EDGAR

Loading ratio trend…

IMRN key financials by period

Reported revenue, net income and operating margin by fiscal year, from Immuron Ltd's annual filings on SEC EDGAR.

Immuron Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2026$7.7M$-3.7M-49.9%
FY 2025$7.3M$-5.2M-73.3%
FY 2024$4.9M$-6.9M-118.3%
FY 2023$1.8M$-3.8M-197.8%
FY 2022$765.2K$-2.9M—
FY 2021$145.8K$-8.4M—
Source: IMRN filings on SEC EDGAR →

About Immuron Ltd (IMRN): stock profile, AI score and financials

Immuron Ltd (IMRN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. IMRN is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $7.7m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2026), Immuron Ltd reports quarterly revenue of $7.7M, net income of $-3.7M, an operating margin of -49.9%. Top institutional holders of IMRN by reported 13-F value include CITADEL ADVISORS, RHUMBLINE ADVISERS, BNP PARIBAS FINANCIAL MARKETS, based on the most recent SEC filings. IMRN trades on the Nasdaq exchange and files with the SEC under CIK 1660046. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IMRN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Immuron Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1660046 →